About LepiDyne
LepiDyne is a company based in Seoul (South Korea) founded in 2019. LepiDyne offers products and services including MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag. LepiDyne operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name (주)레피다인
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LepiDyne
LepiDyne offers a comprehensive portfolio of products and services, including MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag.
Kit for early blood-based diagnosis of liver cancer
Kit for predicting liver cancer treatment outcomes
Kit for monitoring liver cancer treatment progress
Kit for extracting cell-free DNA from blood samples
Funding Insights of LepiDyne
Detailed funding history for LepiDyne
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LepiDyne
Investment portfolio details for LepiDyne
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LepiDyne
Detailed financials for LepiDyne
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lepidyne Comparisons
Peer comparison for LepiDyne
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LepiDyne
LepiDyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of LepiDyne
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lepidyne
Complete news archive for LepiDyne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LepiDyne
LepiDyne was founded in 2019.
LepiDyne is headquartered in Seoul, South Korea.
Young Joon Kim is the current CEO of LepiDyne.
LepiDyne was founded in 2019 in Seoul, South Korea, where tumor-specific DNA methylation markers in blood are discovered, developed, and clinically validated for cancer detection. Operations center on liquid biopsy technologies within the biotechnology sector. Key products, including MethyLiverDx, MethyLiverPro, and MethyLiverMT, are offered for liver cancer diagnostics. Leadership is provided by CEO Young Joon Kim, with activities based in South Korea.
LepiDyne's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
LepiDyne offers MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag.